Home » PATRICK VALLANCE TO HEAD DRUG DISCOVERY AT GLAXOSMITHKLINE
PATRICK VALLANCE TO HEAD DRUG DISCOVERY AT GLAXOSMITHKLINE
GlaxoSmithKline announced today that Patrick Vallance, Head of the Division of Medicine and Professor of Clinical Pharmacology, University College London (UCL), has been named Senior Vice President, Drug Discovery, effective May 1st. He succeeds Allan Baxter, who was recently appointed Senior Vice President, Medicines Development. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-21-2006/0004324210&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May